FC
SGMO

Ferris Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ferris Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,500
Closed -$24K – 535
2019
Q1 		$24K Hold
2,500
– – 0.01% 337
2018
Q4 		$29K Hold
2,500
– – 0.01% 300
2018
Q3 		$42K Hold
2,500
– – 0.02% 275
2018
Q2 		$36K Hold
2,500
– – 0.02% 288
2018
Q1 		$48K Buy
+2,500
New +$53.4K 0.02% 291
2017
Q3 		– Sell
-2,500
Closed -$22K – 497
2017
Q2 		$22K Buy
+2,500
New +$16K 0.01% 350

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ferris Capital's SGMO Position: Q2 2019 in Review

Ferris Capital sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 2,500 shares — an estimated $24K sold.

Ferris Capital first reported a position in SGMO in Q2 2017 and held it in 6 quarters. The position peaked at $48K in Q1 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • Ferris Capital reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • Ferris Capital sold 2,500 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $24K.
  • Ferris Capital first reported a position in SANGAMO THERAPEUTICS INC in Q2 2017 and held it in 6 quarters.
  • Ferris Capital's SANGAMO THERAPEUTICS INC position peaked at $48K in Q1 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on Ferris Capital's 13F filing for Q2 2019, filed 18 Jul 2019.